ClinicalTrials.Veeva

Menu

Human Sperm Markers of Cryodamage Resistance

I

Instituto Valenciano de Infertilidad, IVI Alicante

Status

Completed

Conditions

Fertility

Treatments

Other: Sperm cryopreservation

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT02535377
1406-ALC-048-ES

Details and patient eligibility

About

Sperm freezing has been employed for decades for male fertility preservation in cases of foreseeable or unexpected loss of fertility to guarantee future paternity, and also as a complement of assisted reproduction techniques.

Sperm quality after thawing is highly variable, even among consecutive samples from the same individual, with mean survival rates around 40%. To date, the molecular basis of the adequate resistance or intolerance to freezing/thawing protocols is unknown, and its knowledge can lead to improvement in the selection of the samples to be frozen and also in the adequate supplement of cryopreservation media. Microarray analysis provides a powerful tool to address the molecular explanation beyond this behaviour, yielding results about comparative messenger ribonucleic acid (mRNA)expression under the two different biological conditions: optimal and suboptimal survival.

Then, the aim of the investigators' study is to determine the genomic profile of sperm samples depending on their survival resistance to cryopreservation, to determine genes involved in cryodamage sensitivity.

Full description

Nested cases and controls design, with donor sperm samples frozen under conventional protocols, categorized depending on their good (GSR, n=20) (less than 20% motility decrease) or bad (BSR, n=20) (more than 20% motility decrease) survival rates. Sperm mRNA was extracted using Trizol protocol, suspended in diethylpyrocarbonate (DEPC)-treated water and frozen at -80 degrees until the microarray experiments were performed. RNAs were analyzed on Agilent Bioanalyzer 2100. Samples were pooled in 4 (5 samples/pool and 4 pools/group). Finally, 8 Agilent One colour Whole genome microarray (44K) were performed with pooled samples, 4 microarrays per group.

The results will be evaluate to detect those genes differentially expressed.

Enrollment

40 patients

Sex

Male

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

The criteria used for the inclusion of donors in the sperm bank will be considered:

  • males from 18 to 35 years.
  • good physical and psychological conditions and no hereditary diseases
  • seminal parameters: concentration > 40 million sperm / ml; percentage of progressive motility> 50% percentage of normal forms> 4%.
  • For pregnancy rates after artificial insemination, only women< 40 years without tubal pathologies and artificial insemination indications will be included.

Exclusion criteria

All the population not included in the list of inclusion will be excluded.

Trial design

40 participants in 2 patient groups

High cryoresistance
Description:
High resistance to sperm cryopreservation (decreased sperm motility \<20%)
Treatment:
Other: Sperm cryopreservation
Low cryoresistance
Description:
Low resistance to sperm cryopreservation (decreased sperm motility \>20%)
Treatment:
Other: Sperm cryopreservation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems